Investigating new treatments for asthma using bitter taste receptors
Characterization of biased airway smooth muscle TAS2R agonists for treating asthma
This study is looking for new asthma treatments by finding ways to use special taste receptors in your airways to help relax tight muscles and make it easier to breathe, aiming to create options that work better and don’t lose effectiveness over time.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Florida NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-10758793 on NIH RePORTER |
What this research studies
This research focuses on developing new therapies for asthma by exploring the role of bitter taste receptors found in airway smooth muscle cells. The team aims to identify novel compounds that can activate these receptors to relax constricted airways, which are a major cause of asthma symptoms. By utilizing advanced techniques such as virtual screening and 3D structural analysis, the researchers hope to find effective treatments that do not lead to the common issue of desensitization seen with current medications. The ultimate goal is to improve airflow and reduce asthma-related complications for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with asthma who experience inadequate control of their symptoms with current treatments.
Not a fit: Patients with asthma who respond well to existing bronchodilator therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective asthma treatments that provide better control of symptoms for patients.
How similar studies have performed: While the approach of targeting bitter taste receptors in asthma treatment is relatively novel, similar strategies in other areas of medicine have shown promising results.
Where this research is happening
Tampa, United States
- University of South Florida — Tampa, United States (Active)
Researchers
- Principal investigator: Liggett, Stephen B — University of South Florida
- Study coordinator: Liggett, Stephen B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.